2020 Onsite (also known as 20/20 Onsite) is the only provider solely dedicated to point-of-need eye assessments for clinical trials, proven to meet screening timelines, improve retention rates, and fast-track trials.
With over 85,000 eye exams performed, support for 45 clinical trials, and an average of 11+ years of ophthalmic expertise per clinical employee, 20/20 Onsite delivers unmatched mobile ophthalmic experience for clinical trials. Our innovative approach can reduce participant dropout rates to just 9%, compared to the industry standard of 30%.
With research at risk, ensure quality ocular endpoint protection with 2020 Onsite (20/20 Onsite).
Company Details
- Employees
- 63
- Founded
- -
- Address
- 222 Berkeley Street,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.2020onsite.com
- Keywords
- Healthcare, On-site services, Mobile Healthcare, Preventative Healthcare, Preventive Care, Eye Care, Vision Care, Corporate Well-Being, Clinical Research, Clinical Trial Solutions, Point of Need Eye Assessments, Eye Assessments, Clinical Trials, Clinical Trial Support.
- HQ
- Boston, MA
2020 Onsite Questions
2020 Onsite's website is https://www.2020onsite.com
2020 Onsite's LinkedIn profile is https://www.linkedin.com/company/2020onsite
2020 Onsite has
63 employees.
View email and phone details for 63
employees at 2020 Onsite.
2020 Onsite's industry is
Biotechnology Research
2020 Onsite's top competitors are
Figur8, Inc.,
Sano Genetics,
Zeiss Medical Technology,
Lexitas Pharma Services,
Clinical Enrollment,
Samba Scientific,
Eyecelerator,
Bausch + Lomb,
Charterup,
Ora.
2020 Onsite's categories are Biotechnology Research
2020 Onsite's founding year is 2013
